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Summary
 
To characterize the adhesion cascade that directs lymphocyte homing to peripheral lymph
nodes (PLNs), we investigated the molecular mechanisms of lymphocyte interactions with the
microvasculature of subiliac lymph nodes. We found that endogenous white blood cells and
adoptively transferred lymph node lymphocytes (LNCs) tethered and rolled in postcapillary
high endothelial venules (HEVs) and to a lesser extent in collecting venules. Similarly, firm ar-
rest occurred nearly exclusively in the paracortical HEVs. Endogenous polymorphonuclear
(PMNs) and mononuclear leukocytes (MNLs) attached and rolled in HEVs at similar frequen-
cies, but only MNLs arrested suggesting that the events downstream of primary rolling interac-
tions critically determine the specificity of lymphocyte recruitment. Antibody inhibition stud-
ies revealed that L-selectin was responsible for attachment and rolling of LNCs, and that LFA-1
was essential for sticking. LFA-1–dependent arrest was also abolished by pertussis toxin, impli-
cating a requirement for G
 
a
 
i
 
2
 
-protein–linked signaling. 
 
a
 
4 integrins, which play a critical role
in lymphocyte homing to Peyer’s Patches, made no significant contribution to attachment,
rolling, or sticking in resting PLNs. Velocity analysis of interacting LNCs revealed no detect-
able contribution by LFA-1 to rolling. Taken together, our results suggest that lymphocyte–
HEV interactions within PLNs are almost exclusively initiated by L-selectin followed by a G
protein–coupled lymphocyte-specific activation event and activation-induced engagement of
LFA-1. These events constitute a unique adhesion cascade that dictates the specificity of lym-
phocyte homing to PLNs.
 
T
 
he surveillance of the body for foreign antigens is a
critical function of the immune system. Lymphocytes
migrate from the blood into tissues and secondary lym-
phoid organs, and return back to the blood via lymph ves-
sels and the thoracic duct (1). The majority of lymphocytes
are capable of tissue selective trafficking (termed “hom-
ing”), recognizing organ-specific adhesion molecules on
specialized endothelial cells (2). Tissue-specific homing is
thought to control the extent and scope of immune re-
sponses, and to account for the regional compartmentaliza-
tion of immune system functions (3).
A multistep model for leukocyte homing has been proposed
(4–6), and aspects of it have been confirmed by various in
vitro and in vivo models (7–11). Leukocytes are specifically
recruited by combinatorial molecular events: blood-borne
cells use primary adhesion molecules to tether and roll on
the luminal wall of postcapillary venules, and to encounter
and rapidly transduce signals to upregulate secondary adhe-
sion molecules, which then mediate firm arrest. Thus, a va-
riety of adhesive and/or signaling events are used in unique
combinations to achieve tissue and subset specificity of
homing.
In situ microscopy experiments have demonstrated that
such a multistep model applies to lymphocyte homing to
Peyer’s patches (PPs)
 
1
 
. Bargatze et al. found that initial at-
tachment in PPs is L-selectin–dependent, and that estab-
lished rolling involves both L-selectin and 
 
a
 
4
 
b
 
7 integrins
that interact with the mucosal addressin, MAdCAM-1 (11).
Recent studies in gene-targeted mice have confirmed these
distinct but overlapping functions for L-selectin and 
 
a
 
4
 
b
 
7
 
1
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(12, 13). Subsequent arrest of rolling cells is mediated by
 
a
 
4
 
b
 
7 and LFA-1 integrins, and requires a G protein–linked
signal that is inhibited by lymphocyte treatment with per-
tussis toxin (PTX; reference 9). Thus, in PPs, lymphocyte
homing requires a cascade of four distinct molecular steps.
A similar multistep adhesion cascade may govern lym-
phocyte homing to peripheral lymph nodes (PLNs). For
example, L-selectin deficiency in mice or treatment of wild-
type animals with mAbs to L-selectin or peripheral node
addressin (PNAd), the high endothelial venule (HEV)–spe-
cific ligand for L-selectin, resulted in impaired lymphocyte
homing to PLNs (12, 14–18). Anti–LFA-1 mAbs also re-
duced homing to PLNs, and PLNs in LFA-1–deficient
mice were reportedly smaller than those in heterozygous
littermates (19, 20). Finally, treatment of lymphocytes with
PTX inhibited migration to PLNs (21), and phenotypically
mature thymocytes expressing transgenic PTX homed
poorly in adoptive transfer experiments (22). Thus, lym-
phocyte homing to PLNs appears to require at least three
molecular events: L-selectin binding to PNAd; G protein–
mediated signaling; and engagement of LFA-1. The spatial
and temporal coordination of these events during lympho-
cyte–HEV interactions has not been examined in vivo.
We have used a novel technique to visualize and dissect
interactions of lymphocytes with HEVs in subiliac PLNs of
mice. Our findings confirm that lymphocyte homing to
PLN-HEVs involves a coordinated multistep process, de-
fine important differences from previously described adhe-
sion cascades that mediate homing to other tissues, and
help explain the unique recruitment of lymphocyte subsets
to PLNs.
 
Materials and Methods
 
Reagents.
 
FITC-dextran (10 mg/ml; 150 kD mol mass;
Sigma Chemical Co., St. Louis, MO) and rhodamine 6G (2 mg/
ml; Molecular Probes, Inc., Eugene, OR) were diluted in saline
and undissolved particles were removed by centrifugation; both
reagents were freshly prepared for each experiment. 2
 
9
 
7
 
9
 
,-bis-(2-
carboxyethyl)-5(and 6) carboxyfluorescein (BCECF; Molecular
Probes, Inc.) was prepared as a 0.5 mg/ml stock solution in DMSO
and used within 1 wk. EDTA, PMA, and PTX were all from
Sigma Chemical Co. Mutant PTX (MTX) with a two amino acid
substitution (PT9K129G; reference 23) was a gift of Dr. Rino
Rappuoli (IRIS, Chiron Vaccines Immunobiological Research In-
stitute, Sienna, Italy).
 
Monoclonal Antibodies.
 
mAbs Mel-14 (rat IgG2a, anti–murine
L-selectin; reference 14) and MECA 79 (rat IgM, anti-PNAd;
reference 15) were generated in our laboratories. Hybridoma cells
for these mAbs as well as mAbs Tib 213 (rat IgG2b, anti–murine
CD11a; reference 24) and PS/2 (rat IgG2b, anti–murine 
 
a
 
4,
from American Type Culture Collection, Rockville, MD) were
purified from culture supernatant. mAbs were stored at 
 
2
 
70
 
8
 
C in
endotoxin-free saline at 1 mg/ml. For inhibition studies, 50 
 
m
 
g of
antibody was used to preincubate lymphocytes (5–10 
 
3
 
 10
 
6
 
 cells)
in 0.3–0.5 ml RPMI 1640 (Biowhittaker, Walkersville, MD), 
 
1
 
10% bovine calf serum (cRPMI) for 10 min. Animals were given
an additional 50 
 
m
 
g intravenously 5 min before cell injection to
ensure saturating circulating mAb levels. FITC-conjugated mAbs
to murine CD3 and B220 were from PharMingen (San Diego, CA).
 
Lymphocyte Isolation and Treatment.
 
Lymph node cells (LNCs)
were freshly isolated from PLNs (axillary, brachial, cervical, and
subiliac) and mesenteric (M) LNs. Cells were washed and resus-
pended to 1–2 
 
3
 
 10
 
7
 
 cells/ml in warm cRPMI. Representative
samples were stained with FITC-conjugated mAbs to T and B
cell markers (CD3 and B220, respectively) and determined by
flow cytometry to be 
 
z
 
95% lymphocytes.
For fluorescent labeling, 10 ml of LNCs was incubated with 5 
 
m
 
l
BCECF for 20 min at 37
 
8
 
C. Lymphocytes were centrifuged through
5 ml of warm bovine calf serum and supernatant was discarded. The
pellet was resuspended to 1–2 
 
3
 
 10
 
7
 
 cells/ml in warm cRPMI.
Aliquots of LNCs were pretreated with one or more of the fol-
lowing reagents: various mAbs (see above); PTX, which inacti-
vates 
 
a
 
i-linked G proteins; or MTX, which lacks the enzymatic
activity of native PTX (23). PTX and MTX treatment (100 ng/ml)
was for 2 h at 37
 
8
 
C and was combined with BCECF-labeling
during the final 20 min. Treated cells were washed and used im-
mediately.
 
Animals.
 
We used adult BALB/c mice (Charles River Labo-
ratories, Wilmington, MA) of both sexes (20–30 g body wt).
Mice were housed in a viral antigen–free barrier facility, and kept
on sterilized lab chow and water. All experimental procedures
comply with National Institutes of Health (Bethesda, MD) guide-
lines for the care and use of laboratory animals and were approved
by the Standing Committees on Animals of Harvard Medical
School and The Center for Blood Research.
 
Subiliac LN Preparation and Intravital Microscopy.
 
Mice were anes-
thetized by intraperitoneal injection (10 ml/kg) of physiologic sa-
line containing xylazine (1 mg/ml) and ketamine (5 mg/ml). The
left subiliac LN was prepared for intravital microscopy as previ-
ously described (25). In brief, polyethylene catheters were in-
serted in the right jugular vein and the left carotid artery. A cath-
eter in the right femoral artery was used for injection of cell
suspensions and mAbs. The left subiliac LN was exposed and dis-
sected free of fat tissue. The node was positioned over a micro-
scope slide on a plexiglass stage and kept moist with sterile saline.
Sterile vacuum grease and a glass cover slip were applied to en-
close the preparation for microscopic viewing. The stage was
then placed on an intravital microscope (IV-500; Mikron Instru-
ments, San Diego, CA) equipped with a silicon-intensified target
camera (VE1000SIT; Dage mti, Michigan City, IN). The node
was visualized by bright field transillumination or epifluorescence
from a video-triggered Xenon arc stroboscope (Chadwick Hel-
muth, El Monte, CA). Video images were recorded using a time
base generator (For-A, Montvale, NJ) and a Hi8 VCR (Sony,
Boston, MA). Some experiments included injection of FITC-
dextran solution (2 mg/ml, 10 ml/kg body wt) after recordings of
cell behavior to determine vessel structure, luminal diameter, and
venular order. The latter was determined by counting successive
generations of branches upstream from the epigastric vein as pre-
viously described (25).
 
Analysis of Endogenous White Blood Cell Behavior.
 
Circulating
white blood cells (WBCs) were labeled by intravenous injection
of rhodamine 6G (20 mg/kg body wt). This fluorophor stains nu-
clei and mitochondria. Thus, it allows visualization of myeloid and
lymphoid cells as well as (the more faintly labeled) platelets in the
circulation, whereas RBCs remain unstained. The distinct nuclear
staining patterns of polymorphonuclear (PMNs) and mononu-
clear leukocytes (MNLs) made it possible to distinguish between
these two cell types. An 
 
3
 
100 oil immersion objective with ad-
justable numerical aperture (Carl Zeiss, Inc., Thornwood, NY)
was focused on the upper luminal surface of superficially located
HEVs. Using this approach, we determined the nuclear shape of 
207
 
Warnock et al.
rolling and sticking cells in the plane of focus. Video analyses per-
formed by different blinded observers yielded essentially identical
results, indicating that this method is feasible and reproducible. Be-
tween 16 and 83 consecutive rolling cells per venule were catego-
rized as PMNs and MNLs, respectively. Results are expressed as
frequency of PMNs and MNLs per 100 identifiable cells that
rolled or were stuck (i.e., cells remaining stationary for 
 
>
 
30 s) in
the field of view. Cells that could not be clearly identified (e.g.,
because they were out of focus) were excluded.
Parallel to the video recordings, 20 
 
m
 
l blood samples were
taken from the retroorbital plexus and diluted in Turk’s solution
for differential WBC counts on a hemocytometer.
 
Analysis of BCECF-labeled LNC in PLN-HEVs.
 
Small boluses
(10–50 
 
m
 
l) of BCECF-labeled LNCs (1–2 
 
3
 
 10
 
7
 
 cells/ml) were
retrogradely injected via the femoral artery catheter. LNC behav-
ior in PLNs was recorded through 
 
3
 
10 or 
 
3
 
20 water immersion
objectives (Achroplan, Carl Zeiss Inc.). Cell behavior in individ-
ual vessel segments was determined by playback of video tapes.
Cells were considered noninteracting when they moved at the
velocity of RBCs, whereas detectably lower velocities were de-
fined as rolling. Cells were considered interacting whether they
rolled, arrested, or both. The rolling fraction is the percentage of
cells that interact with a given venule in the total number of cells
that enter that venule during the same period. The sticking frac-
tion is the percentage of interacting cells that become immobile
for 
 
>
 
30 s. In some experiments, sticking LNCs that accumulated
in PLN venules during the 10-min period after intraarterial bolus
injection of 10
 
7
 
 LNCs were counted. LNC accumulation was ex-
pressed as number of sticking cells per mm
 
2
 
 of lumenal surface
area (calculated from venular diameter and length assuming cylin-
drical geometry). A PC-based image analysis system (26) was used
to measure velocities of 
 
>
 
15 consecutive rolling and 20 nonin-
teracting LNCs before and after treatment with mAbs, PTX, or
MTX in one representative venule per animal. Data were used to
determine mean fast cell velocity (V
 
fast
 
), centerline velocity, mean
blood flow velocity (V
 
blood
 
), wall shear rate, and rolling velocity
(V
 
roll
 
) as previously described (25). To correct for the influence of
varying V
 
blood
 
 on rolling, the relative rolling velocity (V
 
rel
 
) was
also calculated according to the following formula: V
 
rel
 
 
 
5
 
 V
 
roll
 
/
V
 
blood
 
 
 
3
 
 100%. V
 
roll
 
 data from different experiments were pooled
to compare treatment effects on V
 
roll
 
 histograms, a sensitive indi-
cator of the strength of rolling interactions.
 
Statistical Methods.
 
Data in graphs and tables are shown as
mean 
 
6
 
 SD, unless otherwise indicated. For statistical compari-
son of two samples, a two-tailed Student’s 
 
t
 
 test was used when
applicable. Multiple comparisons were performed employing the
Kruskal-Wallis test and Bonferoni correction of 
 
P.
 
 Velocity his-
tograms were compared using the Mann-Whitney U-test and the
Kolmogorov-Smirnov test. Differences were considered statisti-
cally significant when 
 
P
 
 
 
,
 
0.05.
 
Results
 
Endogenous Leukocyte Behavior in Subiliac PLNs.
 
Nuclei of
endogenous WBCs were labeled with rhodamine 6G to
study the behavior of PMNs and MNLs in subiliac PLNs
(Fig. 1). In agreement with studies of other organs, we ob-
served heterogeneous adhesive behavior in venules, whereas
arterioles or capillaries did not support interactions. High-
power microscopy of superficial HEV segments allowed us
to distinguish rolling and/or sticking MNLs and PMNs in the
plane of focus. Thus, although some cells could not be cat-
egorized when they were out of focus, it was possible to
determine the relative frequency of subset behavior. Of all
the identifiable rolling WBCs in HEVs (300 cells in 7 HEVs
of 3 animals) the frequency of MNLs was 30%; the remain-
der (70%) were PMNs. The proportion of PMNs in the
rolling population was somewhat higher than their fre-
quency in systemic blood (Fig. 2); differential blood counts
showed that 44 and 56% of circulating WBCs were PMNs
Figure 1. Both PMNs and MNLs roll, but only MNLs stick in PLN-HEVs. Endogenous circulating WBCs were labeled in situ with the nuclear dye
rhodamine 6G. Cells were recorded by fluorescence microscopy through an 3100 objective during their passage through HEVs. The micrographs show
typical scenes in a segment of an order III venule (50-mm diameter, blood flow from top to bottom). Lines were drawn to demarcate lateral borders of the
lumenal compartment. WBCs in the plane of focus show two distinct nuclear staining patterns allowing the identification of PMNs (irregular shape) and
MNLs (homogenous round or oval staining pattern). (A) Two rolling PMNs (arrows) and several sticking MNLs (stars) can be seen. (B) 3.7 s later, one of the
PMNs (A, lower left) has rolled out of the field of view, whereas the other PMN (arrowhead) has continued to roll slowly through the vascular segment.
Sticking MNLs did not change their position. In the meantime, several additional rolling PMNs and MNLs entered the field of view. 
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and MNLs, respectively (the frequency of PMNs is slightly
elevated over normal levels for mice, and most likely re-
flects release of neutrophils from the marginating pool due
to surgical trauma). We conclude that the ability to tether
and roll within HEVs is not specific for lymphocytes, but is
shared by other leukocyte subsets, including neutrophils.
A subpopulation of initially rolling cells eventually ar-
rested, adhering firmly. This behavior was almost exclusively
limited to MNLs, whereas PMNs continued to roll and,
eventually, detached from the vessel wall. Indeed, 23.2 
 
6
 
8.9% (mean 
 
6
 
 SD) of rolling MNLs became stuck during
their observable passage through HEVs, whereas only 0.5 
 
6
 
0.6% of PMNs displayed this behavior (data not shown). Sim-
ilarly, a survey of firmly adherent cells (i.e., cells that were
already stuck when the recording was started and did not
move for at least 30 s thereafter) in HEVs revealed that nearly
all of these cells were MNLs as well (10 HEVs in 3 animals).
 
Behavior of Adoptively Transferred LNCs in PLN-HEVs.
 
Although in situ staining of WBCs permitted the differen-
tiation of the nuclear shape of rolling cells in segments of
some HEVs, rhodamine 6G labeling did not allow us to
perform a selective and quantitative analysis of lymphocyte
behavior in the entire PLN microcirculation. Therefore, we
assessed the adhesive behavior of pooled lymphocytes that
were isolated from peripheral and mesenteric nodes and
stained in vitro with the intracellular fluorophor BCECF.
Labeled LNCs were retrogradely injected through the right
femoral artery and observed during their passage through
the left subiliac PLN.
LNC interactions mirrored the behavior of the endoge-
nous MNLs described above. A fraction (
 
z
 
30% on aver-
age) of LNCs did not interact with the venular walls, but
the majority of cells rolled, especially in higher order ven-
ules. A small fraction of cells exhibited either multiple in-
teractive behaviors (e.g., momentary stops or hesitations,
skipping, variable rolling speeds) or transient arrest and re-
lease (preceded and/or followed by rolling). A significant
number of rolling LNCs (up to 30% in some HEVs) subse-
quently became firmly adherent. Less than 1% became sta-
tionary immediately upon entry into HEVs, a site where
microvascular hemodynamics and endothelial cell proper-
ties may change abruptly.
In contrast to rhodamine 6G staining of WBCs, which
requires high magnification for reliable detection of cells,
BCECF-labeling confers significant brightness and, there-
fore, allows visualization of labeled cells at lower magnifi-
cation (
 
3
 
10 objective) and within a larger field of view.
This permits parallel evaluation of LNC behavior within
different segments of the nodal venular tree. A recent anal-
ysis of the microvascular anatomy of murine subiliac PLNs
has shown that up to five branching orders can be identi-
fied in a typical venular tree (25). One (or more) order I
venule is located in the hilus of subiliac PLNs and drains
into a branch of the extralymphoid superficial epigastric
vein. Order I venules are formed by the merging of smaller
collecting venules (order II) in the nodal medulla that col-
lect blood from higher order postcapillary venules (orders
III–V) in the sub- and paracortex. To determine if there
are segmental differences in lymphocyte recruitment, we
correlated rolling and sticking fractions, as well as the accu-
mulation of sticking LNCs, with the venular order (Fig. 3
 
A
 
). In agreement with previous studies using L-selectin–
transfected lymphoma cells (25), we found that LNCs were
able to attach and roll in all venules draining the node
proper, but rolling fractions were significantly larger in
higher order venules (Fig. 3 
 
B
 
). Likewise, arresting cells
were much more frequently observed in the highest order
venules (Fig. 3 
 
C
 
). The paracortical orders III–V HEVs also
supported the majority of long-term sticking, resulting in
the preferential accumulation of LNCs in these venular
segments (Fig. 3 
 
D
 
). A significant number of HEVs were
noted whose lumen widened abruptly where several capil-
laries converged in the paracortex. This transition results in
an immediate slowing of cells, and may lead to a local dis-
ruption of smooth blood flow, which in turn may aid in
promoting lymphocyte–HEV interactions. It was primarily
at these sites that rare lymphocytes became stuck without
discernible rolling preceding the arrest.
 
Lymphocyte Adhesion in PLN Venules Is L-selectin–depen-
dent.
 
To investigate the contribution of L-selectin to lo-
calization of lymphocytes in PLNs, we pretreated LNCs
with Mel-14, a function-blocking anti–murine L-selectin
mAb. The antibody effect was strikingly complete, inhibit-
ing nearly all interactions of labeled LNCs with the PLN
vasculature (Fig. 4). This differs significantly from previous
intravital microscopy studies in murine PPs, in which anti–
L-selectin only partially reduced interacting fractions (11,
13). In this site, the integrin 
 
a
 
4
 
b
 
7 can also contribute to
lymphocyte tethering and rolling. Thus, we tested whether
Figure 2. Frequency of rolling and sticking MNLs and PMNs in non-
inflamed PLN-HEVs. Nuclei of circulating WBCs were fluorescently la-
beled by intravenous injection of rhodamine 6G. Differential counts of
PMNs and MNLs in systemic blood were determined in parallel to video
recordings of WBC behavior in PLN-HEVs. The frequency of PMNs and
MNLs in the total flux of identifiable rolling cells (16–83 consecutive roll-
ing cells in 7 HEVs of 3 separate preparations) was determined. 10 HEVs
in 3 preparations were scanned to determine the frequency of sticking cell
subsets (i.e., cells that did not move during a 30 s time period). *P ,0.01;
**P ,0.001 versus MNL (Student’s t test).209 Warnock et al.
integrins were similarly able to support LNC rolling in
PLNs. No significant effect on the frequency of rolling was
found with neutralizing antibodies to LFA-1 or a4 inte-
grins.
The Strength of LNC Rolling Interactions Is Integrin- and G
Protein–independent. The  a4b7 integrin component of
LNC rolling in PPs was found to strengthen rolling inter-
actions and to reduce lymphocyte rolling velocity (11, 13).
We asked whether there might be a similarly significant
contribution by a4 or LFA-1 integrins to the strength of
LNC rolling interactions in PLNs. To address this ques-
tion, we compared microvascular hemodynamics and Vroll
histograms by measuring velocities of at least 35 consecu-
tive (>15 rolling and >20 noninteracting) cells in typical
order III HEV before and after antibody treatment (Table
1). Video analysis allowed us to make precise comparisons
of Vroll within the same vessels before and after mAb treat-
ment (Fig. 5, A and B). No significant mAb effect could be
ascertained.
Since Gai-linked signaling pathways are known to be in-
volved in physiologic integrin activation and lymphocyte
homing to PLNs, we also measured the Vroll of LNCs in
which these signaling molecules had been blocked by pre-
treatment with PTX. Excluding those cells that arrested,
there was no significant difference between Vroll profiles of
LNCs treated with functionally active PTX or the inactive
mutant form, MTX, or with untreated cells (Fig. 5 C and
data not shown).
LFA-1 Mediates Firm Adherence of Lymphocytes in PLN-
HEVs. Isolated LNCs and recipient mice were pretreated
with anti-CD11a antibody to block LFA-1–dependent ad-
hesion, and cell behavior was observed within subiliac PLNs.
The mAb treatment essentially abrogated LNC sticking in
all venular orders (Fig. 6). Importantly, sticking was also
abolished when LNC rolling was blocked by treatment
with anti–L-selectin mAb Mel-14, even when LFA-1 func-
tion was not blocked. Treatment with either anti–L-selec-
tin or anti–LFA-1 also eliminated the behavior of the small
subset of LNCs that seemed to arrest immediately upon en-
try into HEVs, without discernible rolling (data not shown).
In contrast, anti-a4 integrin antibody had no statistically
significant effect on LNC sticking.
Rolling Lymphocytes Require Rapid Gai-linked Signaling to
Trigger Sticking in PLN-HEVs. Our findings strongly sug-
gest that LFA-1 is responsible for firm LNC arrest, but not
Figure 3. Lymphocyte interac-
tions in the nodal venular tree are
spatially restricted. (A) Micro-
graphs show a typical subiliac LN
preparation at low (34 objective,
left) and high (320 objective, right)
magnification. The panel on the
left shows the LN embedded in
fatty tissue and partially covered by
the superficial epigastric artery
(SEA) and vein (SEV). Venous
blood from the LN drains into an
extralymphoid side branch of the
SEV via a large order I venule in
the nodal medulla (I in left panel).
An area of the PLN (rectangle on
left) containing some of the tribu-
taries (orders II–V) to this collect-
ing venule is shown on the right
30 min after injection of BCECF-
labeled LNCs (some cells appear
larger because of bleeding of the
bright fluorescence signal and/or
because they are out of focus). In-
teracting LNCs are preferentially
found in high-order HEV, and
rarely stick in order I or II venules.
(B) Rolling fractions and (C) stick-
ing fractions of BCECF-labeled
LNCs in PLN venules were correlated with venular order. LNCs were retrogradely injected into the right femoral artery, and their rolling and sticking
behavior during their initial passage through the LN was analyzed as described in Materials and Methods. Data shown are means 6 SEM of 9 experi-
ments (4–10 venules each). (D) LNC accumulation (10 min after injection of 107 cells) in a representative subiliac LN preparation. Bars depict mean 6
SD of accumulated LNCs in a total of 67 venules.
Figure 4. Lymphocyte rolling
in PLNs is L-selectin–dependent.
LNCs rolling fractions were ana-
lyzed before (control) and after
treatment of cells and animals
with blocking mAbs (a4, mAb
PS/2; LFA-1, mAb Tib 213;
L-selectin, mAb Mel-14). Bars
depict rolling fractions as percent-
age of control cell rolling in the
same venule; data shown are mean 6 SEM of rolling fractions from 3–5
experiments of 4–10 vessels each. **P ,0.001 versus all groups (Kruskal
Wallis test with Bonferoni correction).210 Peripheral Lymph Node Homing
for initial rolling interactions. This integrin is known to re-
quire cell activation signals to become functional (27). Thus,
it seemed likely that a selective activation event was operat-
ing to mediate the transition from L-selectin– to LFA-1–
dependent adhesion in rolling LNCs. We tested the hy-
pothesis that this activation step involved PTX-sensitive
signaling pathway(s). The effect of PTX treatment was
similar to that of anti-CD11a, in that LNCs were able to
attach and roll normally in PLN-HEVs (Fig. 7 A), but were
unable to arrest (Fig. 7 B). In contrast, mutant inactive PTX
Table 1. Venular Microhemodynamics and Rolling Velocities of LNCs
mAb
inhibition
No. Venules/
No. animals Diameter Vfast Vblood WSR (WSS) Vroll (Median) Vrel (Median)
mm mm/s mm/s s21 (dyne/cm2) mm/s %
Control 3/3 38.4 6 5.9 1236 6 603 1105 6 456 228 6 75 (5.6 6 1.9) 38.6 6 21.7 (14.7) 3.4 6 2.8 (2.0)
L-selectin 3/3 38.4 6 5.9 1099 6 266 1168 6 486 250 6 59 (6.3 6 1.5) N/A N/A
Control 4/4 36.2 6 8.5 999 6 521 1150 6 309 267 6 82 (6.7 6 2.1) 24.2 6 18.6 (10.0) 2.7 6 1.8 (0.9)
a4 integrin 4/4 26.2 6 8.5 1456 6 673 1297 6 475 289 6 70 (7.2 6 1.7) 34.1 6 29.5 (15.8) 2.7 6 2.7 (1.3)
Control 3/3 32.7 6 4.8 1103 6 482 1021 6 386 248 6 71 (6.2 6 1.8) 43.0 6 34.9 (32.1) 4.5 6 4.0 (3.5)
LFA-1 3/3 32.7 6 4.8 1109 6 462 1149 6 492 273 6 81 (6.8 6 2.0) 44.9 6 37.6 (30.8) 4.4 6 3.8 (2.6)
MTX 3/3 36.9 6 5.0 1592 6 815 1392 6 949 319 6 91 (8.0 6 2.3) 64.1 6 40.4 (23.2) 4.9 6 3.7 (1.4)
PTX 3/3 36.9 6 5.0 1792 6 809 1569 6 662 332 6 99 (8.3 6 2.5) 66.4 6 48.6 (33.9) 5.2 6 5.0 (1.9)
Mean velocities of noninteracting (Vfast) and rolling (Vroll) LNCs in one representative order III venule per animal were measured. These data to-
gether with the venular diameter were used to calculate Vblood and wall shear rate (WSR) as described in Materials and Methods. The wall shear stress
(WSS) was estimated based on the assumption that the blood viscosity in HEVs is 0.025 Poise. To correct for hemodynamic differences between
control and teatment periods in individual venules that may have mechanically affected LNC rolling behavior, Vroll was also expressed as percentage
of Vfast (Vrel). Anti–L-selectin treatment essentially eliminated LNC rolling in HEVs. Thus, no data for Vroll and Vrel were obtainable. Data shown are
mean 6 SD. Since velocity histograms of Vroll indicate that data were not normally distributed (see Fig. 5), median values are shown as well.
Figure 5. The strength of LNC rolling in HEVs is not augmented by a4 or LFA-1 integrins, and is not PTX sensitive. Frequency histograms were
generated by measuring rolling velocities of individual LNCs in order III venules before (control) and after treatment with (A) anti–LFA-1, (B) anti-a4,
or (C) PTX or MTX. Vroll, Vfast, and Vblood were determined in the same vessels before and after mAb, MTX, or PTX treatment as described in Materials
and Methods (results of hemodynamic measurements are given in Table 1). To account for hemodynamic differences between control and treatment pe-
riod, Vrel was calculated as percentage of Vblood. Frequency distributions were calculated after cells were assigned to velocity classes with Vrel .0% to ,1%,
1% to ,2%, and so on. Statistical comparison of population means and distributions revealed no significant differences between rolling velocities (P
.0.05).211 Warnock et al.
(MTX) did not inhibit LNC sticking. The mutant form of
PTX contains two amino acid substitutions (Arg9®Lys and
Glu129®Gly) and retains the ability to interact with cell
membranes, but lacks the enzymatic ability to ADP-ribosy-
late ai subunits of heterotrimeric G proteins (23). Thus, it
seems likely that the blockade of sticking by PTX was due
to inactivation of G protein–linked signaling, and not due
to intrinsic surface modifications and/or steric hindrance of
requisite surface molecules.
Discussion
We have examined the interactions of blood-borne leu-
kocytes with PLN-HEVs in order to dissect the molecular
mechanisms of lymphocyte homing to PLNs. The experi-
mental data suggest that an organ-specific adhesion cascade
operates within resting PLNs that is selective for and effi-
cient in recruiting naive lymphocytes, while excluding my-
eloid cells or lymphocyte populations that express little or
no L-selectin (Fig. 8). Although L-selectin mediates attach-
ment and rolling interactions in PLN-HEVs, LFA-1 was
required for subsequent lymphocyte sticking. Adhesion via
LFA-1, but not L-selectin, was inhibited by PTX, indicat-
ing that heterotrimeric G protein signaling is required for
affinity upregulation of LFA-1. This cascade of molecular-
adhesive events in PLNs is similar to, but molecularly dis-
tinct from, those previously characterized for lymphocyte
homing to PPs and intestinal lamina propria, and for granu-
locyte accumulation in other organs (11, 28, 29).
Previous ultrastructural and histologic studies of the PLN
subcortex and medulla have suggested that lymphocyte ex-
travasation may occur preferentially within paracortical ven-
ules that feature specialized luminal morphology. These post-
capillary vessels (corresponding to order IV and V venules
in subiliac LNs) are lined by high cuboidal endothelial cells.
Further downstream, endothelial cells are arranged in an
overlapping plate pattern followed by a smooth layer of flat
endothelial cells that is indistinguishable from nonlymphoid
microvessels (corresponding to the lining of order I and II
venules; references 1, 30, 31). The counter-receptors for
L-selectin and LFA-1 are found in abundance on the lumi-
nal surface of postcapillary HEVs, and in particular on
ridgelike structures that may further facilitate or reinforce
cellular interactions (32, 33). Our results provide a func-
tional correlate for these morphologic observations: leuko-
Figure 6. Lymphocyte sticking in PLN-HEVs is mediated by LFA-1.
The fraction of rolling LNCs that became stuck for >30 s was determined
before (control) and after treatment of cells and animals with blocking
mAbs (a4, mAb PS/2; LFA-1, mAb Tib 213; L-selectin, mAb Mel-14).
Bars depict sticking fractions as percentage of control cell sticking in the
same venule; data shown are mean 6 SEM of sticking fractions from 3–5
experiments (4–10 venules each). **P ,0.001 versus a4 and control
group (Kruskal Wallis test with Bonferoni correction).
Figure 7. Sticking of LNCs in PLN-HEV, but not rolling, is blocked
by PTX. To test the role of Gai-linked proteins, LNCs were treated with
PTX or the inactive mutant form, MTX, as a control. Cells were labeled
with BCECF and injected into the feeding artery of a subiliac PLN. (A)
Rolling and (B) sticking fractions of treated LNCs in subiliac LN venules
were determined. Data are shown as mean 6 SEM of 3 experiments (5–10
venules each). **P ,0.001 (Student’s t test).
Figure 8. Homing to PLN is mediated by a unique cascade of molecu-
lar adhesive and signaling events. At least three distinct steps must occur
for lymphocyte homing via HEVs. Only cells that express L-selectin at
sufficient density can tether and roll via binding to PNAd (Step 1). Most
lymphocytes (such as subsets of activated/memory cells) that express little
or no L-selectin pass HEVs without interacting. Subsequently, rolling
cells must encounter a Gai-linked activating stimulus (Step 2) which trig-
gers functional upregulation of LFA-1 (Step 3). Rolling PMNs cannot re-
spond to this lymphocyte-specific chemoattractant signal. The unique
combination of these consecutive steps results in the highly efficient and
selective recruitment of preferentially naive lymphocytes.212 Peripheral Lymph Node Homing
cyte rolling and lymphocyte sticking were spatially regu-
lated, occurring preferentially in high order subcortical
venules. Thus, our studies confirm those of Marchesi and
Gowans who proposed over 30 years ago that lymphocyte
homing is a unique feature of HEV in the nodal paracortex
(31).
Early experiments in mice demonstrated the inhibition
of lymphocyte homing to PLNs by treatment with mAb
Mel-14 to murine L-selectin and thus L-selectin has been
dubbed the lymphocyte homing receptor (14). In addition
to its well-known function as a mediator of leukocyte roll-
ing, recent studies have shown that L-selectin ligation can
induce intracellular signaling events (34, 35) and that exten-
sive antibody- or ligand-induced cross-linking of L-selectin
can trigger functional upregulation of b2 integrins in neutro-
phils and lymphocytes (36, 37). Our analysis of LNCs and
endogenous leukocyte behavior demonstrates that L-selec-
tin is both necessary and sufficient for tethering and rolling
of LNCs in all venular orders, but suggests that L-selectin
engagement alone is insufficient to induce sticking.
On rolling cells, L-selectin engagement is presumably
brief and restricted to the small fraction of total L-selectin
molecules within the area of contact with the vessel wall.
Our results show that L-selectin–mediated rolling of PMNs
in HEVs was rarely followed by sticking, and a detailed
analysis of Vrolls suggests that the strength of LNC rolling
interactions was not influenced by LFA-1 or a4 integrins.
Moreover, L-selectin signaling has been reported to be in-
sensitive to PTX (34), whereas LNC sticking in HEVs was
essentially abrogated by PTX pretreatment. Thus, L-selec-
tin signaling, if it occurs during lymphocyte–HEV interac-
tions, does not appear sufficient to mediate arrest or alter
rolling through integrin activation. However, our studies
do not exclude the possibility that L-selectin signaling may
synergize with other activation pathways that involve PTX-
sensitive G proteins.
Lymphocytes from noninflamed lymph nodes are primarily
naive T and B cells that are characteristically L-selectinhi,
LFA-11, and a4Io (38, 39). Consistent with this specialized
array of surface adhesion molecules, naive lymphocytes are
the predominant subset that enters PLNs via HEVs (39,
40). The finding that LNC accumulation in murine PLNs
is dependent on L-selectin implies that lymphocytes that do
not express L-selectin, or express only low levels, may be
excluded from homing to PLNs because they cannot tether
and roll along the vessel wall. L-selectinlow lymphocyte
populations may include many recently activated cells as
well as a sizable fraction (z30%) of circulating memory cells
(38, 39). On the other hand, these results suggest that, un-
less precluded by the existence of naive cell-specific activat-
ing factors, memory cell subsets that express L-selectin and
LFA-1 should be capable of homing to PLNs via the HEV
route. Indeed, recent short-term homing studies of splenic
memory T cell subsets indicate that a significant number of
memory cells retain a significant capacity to home via PLN-
HEVs in mice (39).
The concept that L-selectin is essential for lymphocyte
traffic to PLNs is also in agreement with the phenotype of
L-selectin–deficient mice, which display an z90% reduc-
tion in the size and cellularity of PLNs due to a greatly re-
duced influx of lymphocytes via HEV (12, 16–18). The
majority of resident lymphocytes in the PLNs of these ani-
mals display a memory phenotype, and it has been pro-
posed that these cells arrive in PLNs predominantly via af-
ferent lymph vessels (18). However, it is possible that some
L-selectin–deficient cells may reach PLNs after adhering to
HEVs through an alternative pathway. We have previously
shown that circulating activated platelets can bridge be-
tween L-selectin deficient lymphocytes and HEVs because
platelet P-selectin mediates platelet tethering to both P-selec-
tin glycoprotein ligand 1 (PSGL-1) on lymphocytes and
PNAd on HEVs (41, 42). Consistent with this idea, we
have previously shown that the rolling of endogenous WBCs
in wild-type mice was not completely inhibitable by anti–
L-selectin mAb (41). Moreover, z10% of the WBCs that
passed through PLNs in L-selectin–deficient mice rolled in
HEVs (42). The fact that LNCs did not display L-selectin–
independent rolling in our experiments does not contradict
this platelet delivery concept. It is unlikely that LNCs had
significant numbers of platelets on their surface because
they were directly isolated from LNs and washed exten-
sively before injection, and LNC behavior was only ana-
lyzed for a short time (seconds to minutes) after intraarterial
injection. This period may not have been sufficient to al-
low significant association with activated platelets which
may be infrequently encountered in the blood stream.
Lymphocyte homing to PLNs in LFA-1–deficient mice
has not been directly examined as yet. However, PLNs in
these mice are reportedly smaller than those of wild-type
littermates (20). Moreover, it has been reported that al-
though systemically-induced delayed type hypersensitivity
responses are apparently normal in the absence of LFA-1
(43), recall responses to cutaneously applied antigen are se-
verely impaired in LFA-1–deficient mice (20). This pheno-
type is similar to that of L-selectin–deficient mice in which
an inability to mount a cutaneous hypersensitivity response
was shown to be due to the lack of naive lymphocyte hom-
ing to the draining PLNs where cutaneous antigens are
presented (16, 17). Our findings demonstrating LFA-1 in-
volvement in lymphocyte arrest in PLN–HEVs may pro-
vide an explanation for these observations, suggesting that
the inefficient cutaneous response in LFA-1–deficient mice
may reflect a defect in normal sensitization of lymphocytes
within PLNs.
LFA-1 exists in an inactive state on resting LNCs, but its
ligand binding activity may be rapidly modulated by a vari-
ety of mechanisms (27, 44–46). In addition to L-selectin cross-
linking (discussed above), several distinct signaling pathways
have been implicated in b2 integrin activation, including li-
gation of lymphocyte antigen receptors and chemoattractant
receptors that signal through heterotrimeric G proteins.
The latter include receptors for physiologic chemoattract-
ants such as chemokines, a class of receptors whose signal-
ing is both rapid and sensitive to inactivation by PTX (46, 47).
We found that LFA-1–dependent firm adhesion of
LNCs in PLN-HEVs was PTX-sensitive, analogous to prior213 Warnock et al.
studies of LNC homing to PPs (9, 11). However, the
PTX-induced inhibition of LNC sticking in PPs was re-
versible by LNC activation with PMA, a phorbol ester that
directly activates protein kinase C (9). We attempted but
were unable to circumvent the effects of PTX inhibition
on LNC sticking in PLN-HEVs by PMA pretreatment of
LNCs before injection. PMA has been shown to upregu-
late the affinity of leukocyte integrins, including LFA-1 (48)
and a4b7 (49), but PMA treatment also causes rapid shed-
ding of L-selectin and resulted in a dramatic reduction in
LNC rolling in PLN-HEVs (reference 50 and data not
shown). We performed additional in vitro studies using a
parallel plate flow chamber (41) and affinity-isolated PNAd
and intercellular adhesion molecule (ICAM)–1, endothelial
ligands for L-selectin and LFA-1, respectively. PMA in-
duced equivalent sticking of both PTX and mutant toxin–
treated LNCs to ICAM-1 under static conditions or at low
shear (1.6 dyne/cm2) within a narrow temporal window
(4.5–6 min after activation, our unpublished observation).
Surface-expressed L-selectin was concomitantly downregu-
lated, resulting in a failure of most cells to tether to the coated
substrate at higher shear rates or at later time points. In con-
trast to PLNs, primary adhesion of LNCs in PPs can be al-
ternatively mediated by either L-selectin or a4b7 (11). Thus,
the ability of PMA-activated, PTX-treated LNCs to stick
in PP-HEVs, but not PLN-HEVs, was most likely due to
the differential contribution by a4b7 to primary adhesion
and may also have resulted in more efficient sticking in PP-
HEVs afforded by the synergy of activated a4b7 and LFA-1.
Taken together, our results suggest that rolling lympho-
cytes are activated in PLN-HEVs by one or more potent
adhesion-triggering chemoattractant(s) that exert their effect
via Gai-coupled lymphocyte surface receptor(s). Our ob-
servations suggest that unless one postulates signals occur-
ring before lymphocyte entry into HEVs, the signaling event
must be capable of triggering LFA-1 in less than 1 s. Inter-
estingly, we noted LNCs to be extraordinarily sensitive to
temperature effects: LNC preparations that were not care-
fully kept at 378C before intraarterial injection rolled nor-
mally in HEVs, but were incapable of sticking during their
initial passage through HEVs (our unpublished observation).
This indicates that the efficient detection and processing of
the chemoattractant signal and/or the subsequent integrin
response are critically dependent on unperturbed cellular
metabolism. While the identity of the lymphocyte chemo-
attractant(s) in PLN-HEVs remain(s) to be determined, our
findings do not exclude the possibility that signals which
upregulate LFA-1 affinity may be sufficient for arrest, but
insufficient for subsequent diapedesis.
Our results imply that the recruitment of (mostly naive)
lymphocytes to PLNs is also controlled in part by a selec-
tive ability to recognize specific chemoattractant(s). Nearly
all granulocytes and 70–80% of all circulating lymphocytes
(constituting the majority of MNLs) express L-selectin (51).
The observation that rolling PMNs in PLN-HEVs were
slightly more frequent than MNLs when compared to their
respective frequency in the blood stream is consistent with
the differential prevalence of L-selectin1 cells in the two
subsets. However, as originally noted by Lewinsohn et al.,
the distinction between granulocyte and lymphocyte re-
cruitment to PLNs is not based on differential engagement
of the homing receptor L-selectin (51). Although both
PMNs and MNLs are known to express LFA-1 in an inac-
tive or low-affinity conformation (27), we observed that
endogenous MNLs, but not PMNs, could firmly arrest in
PLN-HEVs. This implies that the HEV-specific activation
signal was selectively detected by rolling lymphocytes, but
not by myeloid cells. Though variations in homing recep-
tor expression reflect differentiation of lymphocyte sub-
populations (and critically impact recirculatory routes), the
possible role that chemoattractants may play in regulating
subpopulation homing (e.g., naive versus memory lympho-
cytes) remains to be determined.
The data presented here describe lymphocyte homing to
PLNs as similar to, but distinct from, the multi-step adhe-
sion cascade in PPs, which requires lymphocyte a4b7 in-
teraction with endothelial MAdCAM-1. In this site, a4b7
plays a critical bridging role, slowing the L-selectin–initiated
rolling of cells sufficiently to allow LFA-1 engagement. In
addition, a4b7 can also mediate tethering (albeit less effi-
ciently than L-selectin), thus allowing some lymphocytes to
home to PPs in an L-selectin–independent manner. Indeed,
although anti–L-selectin greatly reduced the total leukocyte
rolling flux in PP-HEVs (65–90%), the fraction of lympho-
cytes that entered PP-HEVs and subsequently became stuck
was reduced by only 35% (11, 13). Although lymphocyte
homing to rat PLNs has been reported to involve a4 inte-
grins, and expression of the a4 integrin ligand VCAM-1
has been found in rat PLN-HEVs (52), most HEVs in un-
inflamed adult murine and human PLNs were reported to
express little, if any, MAdCAM-1 or vascular cell adhesion
molecule 1 (VCAM-1; 53–55). This is consistent with our
present findings and with earlier homing studies using anti-
a4 mAbs or b7-deficient animals (13, 56, 57).
The apparent lack of a requisite bridging adhesive inter-
action between L-selectin and b2 integrin engagement in
PLNs may reflect the much higher density of L-selectin
ligands on PLN-HEVs, which alone may allow sufficiently
strong and slow rolling interactions (15). Our analysis of
hemodynamic parameters presented here and in an earlier
report (25) indicate that, on average, Vblood (1.1 6 0.5 mm/s
versus 3.2 6 0.2 mm/s) and WSR (228 6 75 s21 versus
418 6 39 s21) are significantly lower in PLN venules than
those encountered in PP-HEVs (58), yet the Vroll is similar
(11, 58). Although the requirement for a4b7 in PP hom-
ing may reflect the greater need for strengthened rolling
adhesions to allow sufficient slowing for LFA-1 engage-
ment, the dissimilar requirements of PLN and PP homing
clearly provide a mechanism for the differential recruitment
of compartmentalized lymphocyte subsets (39).
However, our results do not formally exclude the exis-
tence of additional intermediate adhesive interactions in PLNs.
In addition to the platelet delivery mechanism (discussed
above), a number of other receptors have been implicated
in PLN homing, such as the hyaluronate receptor CD44
and the mucin CD43 on lymphocytes, and vascular adhe-214 Peripheral Lymph Node Homing
sion protein 1 (VAP-1) expressed on human PLN-HEVs
(59–61). On the other hand, the strikingly complete inhibi-
tion of LNC rolling and sticking by mAbs to L-selectin and
LFA-1, respectively, suggests that any additional molecular
adhesive pathways (other than platelet P-selectin) are un-
able to confer detectable mechanical stability to either of these
events under the experimental conditions employed here.
In conclusion, we have demonstrated a unique adhesion
cascade mediating lymphocyte homing to PLN-HEVs. We
have confirmed the site of lymphocyte adhesion in PLNs as
high-order subcortical post-capillary venules, and have re-
fined the understanding of leukocyte adhesive behavior
therein. The critical roles of L-selectin for attachment and
rolling and affinity-upregulated LFA-1 for firm adhesion in
normal lymph nodes have profound implications for the re-
circulatory routes of naive and memory lymphocyte popu-
lations, and illustrate the singular role that chemoattractant
signals play in recruiting or excluding leukocyte subsets
from specialized tissues.
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